Sticky situation: Localized adherence of enteropathogenic Escherichia coli to the small intestine epithelium

Future Microbiology

Volumn 5, Issue 11, 2010, Pages 1645-1661

  Humphries, Romney M ^a   Armstrong, Glen D ^a  

^a NONE

Author keywords

adherence; enteropathogenic Escherichia coli; type III secretion; type IV pili

Indexed keywords

BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CELL ADHESION; ENTEROPATHOGENIC ESCHERICHIA COLI; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; INTESTINE EPITHELIUM; KNOWLEDGE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BACTERIAL ADHESION; BIOMEDICAL RESEARCH; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIUM; HUMANS; INTESTINE, SMALL;

ESCHERICHIA COLI;

EID: 78650219017     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.124     Document Type: Review

References (169)

1. Giles C, Sangster G, Smith J: Epidemic gastro-enteritis of infants in Aberdeen during 1947. Arch. Dis. Child. 24(117), 45-53 (1949).
2. Giles C, Sangster MB: An outbreak of infantile gastroenteritis in Aberdeen. J. Hyg. (Lond.) 46, 1-9 (1948).
3. Taylor J, Powell BW, Wright J: Infantile diarrhoea and vomiting; a clinical and bacteriological investigation. BMJ 2(4619), 117-125 (1949).
4. Taylor J, Charter RE: The isolation of serological types of Bact. coli in two residential nurseries and their relation to infantile gastroenteritis. J Pathol. Bacteriol. 64(4), 715-728 (1952).
5. Kauffmann F, Dupont A: Escherichia strains from infantile epidemic gastro enteritis. Acta Pathol. Microbiol. Scand. 27(4), 552-564 (1950).
6. Smith J: The association of certain types (a and b) of Bact. coli with infantile gastro-enteritis. J. Hyg. (Lond.) 47(3), 221-226 (1949).
7. Bray J: Bray's discovery of pathogenic Esch. coli as a cause of infantile gastroenteritis. Arch. Dis. Child. 48, 923-926 (1973).
8. Levine MM, Edelman R: Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis. Epidemiol. Rev. 6, 31-51 (1984).
9. Neter E: Enteritis due to enteropathogenic Escherichia coli; present-day status and unsolved problems. J. Pediatr. 55(2), 223-239 (1959).
10. Neter E: Enteritis due to enteropathogenic Escherichia coli. Am. J. Dig. Dis. 10(10), 883-886 (1965).
11. Kauffmann F: The serology of the coli group. J. Immunol. 57, 71-100 (1947).
12. Neter E, Westphal O, Luderitz O, Gino RM, Gorzynski EA: Demonstration of antibodies against enteropathogenic Escherichia coli in sera of children of various ages. Pediatrics 16(6), 801-808 (1955).
13. Gross RJ, Scotland SM, Rowe B: Enterotoxin testing of Escherichia coli causing epidemic infantile enteritis in the U.K. Lancet 1(7960), 629-631 (1976).
14. Echevarria P, Blacklow NR, Sanford LB et al.: Enterotoxigenicity and invasive capacity of "enteropathogenic" serotypes of Escherichia coli. J. Pediatr. 89, 8-10 (1976).
15. Goldschmidt MC, DuPont HL: Enteropathogenic Escherichia coli: lack of correlation of serotype with pathogenicity. J. Infect. Dis. 133(2), 153-156 (1976).
16. Sack RB: Letter: serotyping of E. coli. Lancet 1(7969), 1132 (1976).
17. Gurwith MJ, Wiseman DA, Chow P: Clinical and laboratory assessment of the pathogenicity of serotyped enteropathogenic Escherichia coli. J. Infect. Dis. 135(5), 735-743 (1977).
18. Gangarosa EJ, Merson MH: Epidemiologic assessment of the relevance of the so-called enteropathogenic serogroups of Escherichia coli in diarrhea. N. Engl. J. Med. 296(21), 1210-1213 (1977).
19. Kirby AC, Hall EG, Coackley W: Neonatal diarrhoea and vomiting; outbreaks in the same maternity unit. Lancet 2(6623), 201-207 (1950).
20. Koya G, Kosakai N, Fukasawa Y: Supplementary studies on the multiplication of Escherichia coli O-111 B4 in the intestinal tract of adult volunteers and its relation to manifestation of coli enteritis. Jpn. J. Med. Sci. Biol . 7(6), 655-661 (1954).
21. Koya G, Kosakai N, Kono M, Mori M, Fukasawa Y: Observations on the multiplication of Escherichia coli O-111 B4 in the intestinal tract of adult volunteers in feeding experiments, the intubation study with Miller-Abbott's double lumen tube. Jpn. J. Med. Sci. Biol. 7(2), 197-203 (1954).
22. Neter E, Shumway CN: E. coli serotype D433: occurrence in intestinal and respiratory tracts, cultural characteristics, pathogenicity, sensitivity to antibiotics. Proc. Soc. Exp. Biol. Med. 75(2), 504-507 (1950).
23. June RC, Ferguson WW, Worfel MT: Experiments in feeding adult volunteers with Escherichia coli 55, B5, a coliform organism associated with infant diarrhea. Am. J. Hyg. 57(2), 222-236 (1953).
24. Ferguson W W, June RC: Experiments on feeding adult volunteers with Escherichia coli 111, B4, a coliform organism associated with infant diarrhea. Am. J. Hyg. 55(2), 155-169 (1952).
25. Neter E, Zalewski NJ, Ferguson WW: Escherichia coli hemagglutinin response of adult volunteers to ingested E. coli 055 B5. Proc. Soc. Exp. Biol. Med. 82(2), 215-219 (1953).
26. Wentworth FH, Brock DW, Stulberg CS, Page RH: Clinical, bacteriological, and serological observations of two human volunteers following ingestion of Escherichia coli O127:B8. Proc. Soc. Exp. Biol. Med. 91(4), 586-588 (1956).
27. Thomson S: The role of certain varieties of Bacterium coli in gastro-enteritis of babies. J. Hyg. (Lond.) 53(3), 357-367 (1955).
28. Ulshen MH, Rollo JL: Pathogenesis of Escherichia coli gastroenteritis in man - another mechanism. N. Engl. J. Med. 302(2), 99-101 (1980).
29. Taylor CJ, Hart A, Batt RM, McDougall C, McLean L: Ultrastructural and biochemical changes in human jejunal mucosa associated with enteropathogenic Escherichia coli (0111) infection. J. Pediatr. Gastroenterol. Nutr. 5(1), 70-73 (1986).
30. Rothbaum RJ, Partin JC, Saalfeld K, McAdams AJ: An ultrastructural study of enteropathogenic Escherichia coli infection in human infants. Ultrastruct. Pathol. 4(4), 291-304 (1983).
31. Rothbaum R, McAdams AJ, Giannella R, Partin JC: A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants. Gastroenterology 83(2), 441-454 (1982).
32. Drucker MM, Polliack A, Yeivin R, Sacks TG: Immunofuorescent demonstration of enteropathogenic Escherichia coli in tissues of infants dying with enteritis. Pediatrics 46(6), 855-864 (1970).
33. Clausen CR, Christie DL: Chronic diarrhea in infants caused by adherent enteropathogenic Escherichia coli. J. Pediatr. 100(3), 358-361 (1982).
34. Staley TE, Corley LD, Jones EW: Malabsorption in neonatal pigs monocontaminated with Escherichia coli (055B5). Am. J. Dig. Dis. 17(3), 239-247 (1972).
35. Staley TE, Corley LD, Jones EW: Early pathogenesis of colitis in neonatal pigs monocontaminated with Escherichia coli. Fine structural changes in the colonic epithelium. Am. J. Dig. Dis. 15(10), 923-935 (1970).
36. Moon HW, Whipp SC, Argenzio RA, Levine MM, Giannella RA: Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect. Immun. 41(3), 1340-1351 (1983).
37. Chen HD, Frankel G: Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol. Rev. 29(1), 83-98 (2005).
38. Cravioto A, Gross RJ, Scotland SM: An adhesive factor found in strains of Escherichia coli belonging to the traditional infantile enteropathogenic serotypes. Curr. Microbiol. 3, 95-99 (1979).
39. Baldini MM, Kaper JB, Levine MM, Candy DC, Moon HW: Plasmid-mediated adhesion in enteropathogenic Escherichia coli. J. Pediatr. Gastroenterol. Nutr. 2(3), 534-538 (1983).
40. Scaletsky IC, Silva ML, Trabulsi LR: Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells. Infect. Immun. 45(2), 534-536 (1984).
41. Nataro JP, Scaletsky IC, Kaper JB, Levine MM, Trabulsi LR: Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Escherichia coli. Infect. Immun. 48(2), 378-383 (1985).
42. Knutton S, Baldini MM, Kaper JB, McNeish AS: Role of plasmid-encoded adherence factors in adhesion of enteropathogenic Escherichia coli to HEp-2 cells. Infect. Immun. 55(1), 78-85 (1987).
43. Donnenberg MS, Kaper JB, Finlay BB: Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol. 5(3), 109-114 (1997).
44. Nougayrede JP, Fernandes PJ, Donnenberg MS: Adhesion of enteropathogenic Escherichia coli to host cells. Cell. Microbiol. 5(6), 359-372 (2003).
45. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB: Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91(4), 511-520 (1997).
46. Knutton S, Lloyd DR, McNeish AS: Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. Infect. Immun. 55(1), 69-77 (1987).
47. Donnenberg MS, Kaper JB: Enteropathogenic Escherichia coli. Infect. Immun. 60(10), 3953-3961 (1992).
48. Hernandes RT, Elias WP, Vieira MA, Gomes TA: An overview of atypical enteropathogenic Escherichia coli. FEMS Microbiol. Lett. 297(2), 137-149 (2009).
49. Trabulsi LR, Keller R, Tardelli Gomes TA: Typical and atypical enteropathogenic Escherichia coli. Emerg. Infect. Dis. 8(5), 508-513 (2002).
50. McNeish AS, Turner P, Fleming J, Evans N: Mucosal adherence of human enteropathogenic Escherichia coli. Lancet 2(7942), 946-948 (1975).
51. Nataro JP, Baldini MM, Kaper JB, Black RE, Bravo N, Levine MM: Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe. J. Infect. Dis. 152(3), 560-565 (1985).
52. Scotland SM, Richmond JE, Rowe B: Adhesion of enteropathogenic strains of Escherichia coli (EPEC) to HEp-2 cells is not dependent on the presence of fmbriae. FEMS Microbiol. Lett. 20(2), 191-195 (1983).
53. Ofek I, Mirelman D, Sharon N: Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature 265(5595), 623-625 (1977).
54. Giron J A, Qadri F, Azim T, Jarvis KJ, Kaper JB, Albert MJ: Monoclonal antibodies specific for the bundle-forming pilus of enteropathogenic Escherichia coli. Infect. Immun. 63(12), 4949-4952 (1995).
55. Giron JA, Ho AS, Schoolnik GK: Characterization of fmbriae produced by enteropathogenic Escherichia coli. J. Bacteriol 175(22), 7391-7403 (1993).
56. Giron JA, Ho AS, Schoolnik GK: An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science 254(5032), 710-713 (1991).
57. Puente JL, Bieber D, Ramer SW, Murray W, Schoolnik GK: The bundle-forming pili of enteropathogenic Escherichia coli: transcriptional regulation by environmental signals. Mol. Microbiol. 20(1), 87-100 (1996). (Pubitemid 26126049)
58. Donnenberg MS, Giron JA, Nataro JP, Kaper JB: A plasmid-encoded type IV fmbrial gene of enteropathogenic Escherichia coli associated with localized adherence. Mol. Microbiol. 6(22), 3427-3437 (1992).
59. Craig L, Li J: Type IV pili: paradoxes in form and function. Curr. Opin. Struct. Biol. 18(2), 267-277 (2008).
60. Giron JA, Gomez-Duarte OG, Jarvis KG, Kaper JB: Longus pilus of enterotoxigenic Escherichia coli and its relatedness to other type-4 pili - a minireview. Gene 192(1), 39-43 (1997).
61. Pugsley AP: The complete general secretory pathway in Gram-negative bacteria. Microbiol. Rev. 57(1), 50-108 (1993).
62. Pelicic V: Type IV pili: e pluribus unum? Mol. Microbiol. 68(4), 827-837 (2008).
63. Blank TE, Lacher DW, Scaletsky IC, Zhong H, Whittam TS, Donnenberg MS: Enteropathogenic Escherichia coli O157 strains from Brazil. Emerg. Infect. Dis. 9(1), 113-115 (2003).
64. Blank TE, Zhong H, Bell AL, Whittam TS, Donnenberg MS: Molecular variation among type IV pilin (bfpA) genes from diverse enteropathogenic Escherichia coli strains. Infect. Immun. 68(12), 7028-7038 (2000).
65. Fernandes PJ, Guo Q, Donnenberg MS: Functional consequences of sequence variation in bundlin, the enteropathogenic Escherichia coli type IV pilin protein. Infect. Immun. 75(10), 4687-4696 (2007).
66. Craig L, Volkmann N, Arvai AS et al.: Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions. Mol. Cell. 23(5), 651-662 (2006).
67. Ramboarina S, Fernandes PJ, Daniell S et al.: Structure of the bundle-forming pilus from enteropathogenic Escherichia coli. J. Biol. Chem. 280(48), 40252-40260 (2005).
68. Donnenberg MS, Zhang HZ, Stone KD: Biogenesis of the bundle-forming pilus of enteropathogenic Escherichia coli: reconstitution of fmbriae in recombinant E. coli and role of DsbA in pilin stability - a review. Gene 192(1), 33-38 (1997).
69. Hwang J, Bieber D, Ramer SW, Wu CY, Schoolnik GK: Structural and topographical studies of the type IV bundle-forming pilus assembly complex of enteropathogenic Escherichia coli. J. Bacteriol. 185(22), 6695-6701 (2003).
70. Crowther LJ, Anantha RP, Donnenberg MS: The inner membrane subassembly of the enteropathogenic Escherichia coli bundle-forming pilus machine. Mol. Microbiol. 52(1), 67-79 (2004).
71. Zhang HZ, Donnenberg MS: DsbA is required for stability of the type IV pilin of enteropathogenic Escherichia coli. Mol. Microbiol. 21(4), 787-797 (1996).
72. Skerker JM, Berg HC: Direct observation of extension and retraction of type IV pili. Proc. Natl Acad. Sci. USA 98(12), 6901-6904 (2001).
73. Anantha RP, Stone KD, Donnenberg MS: Role of BfpF, a member of the PilT family of putative nucleotide-binding proteins, in type IV pilus biogenesis and in interactions between enteropathogenic Escherichia coli and host cells. Infect. Immun. 66(1), 122-131 (1998).
74. Bieber D, Ramer SW, Wu CY et al.: Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science 280(5372), 2114-2118 (1998).
75. Humphries RM, Griener TP, Vogt SL et al.: N-acetyllactosamine-induced retraction of bundle-forming pili regulates virulence-associated gene expression in enteropathogenic Escherichia coli. Mol. Microbiol. 76(5), 1111-1126 (2010).
76. Knutton S, Baldwin T, Williams PH, McNeish AS: Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 57(4), 1290-1298 (1989).
77. McConnell MM, Chart H, Scotland SM, Smith HR, Willshaw GA, Rowe B: Properties of adherence factor plasmids of enteropathogenic Escherichia coli and the effect of host strain on expression of adherence to HEp-2 cells. J. Gen. Microbiol. 135(5), 1123-1134 (1989). (Pubitemid 19135394)
78. Rosenshine I, Duronio V, Finlay BB: Tyrosine protein kinase inhibitors block invasin-promoted bacterial uptake by epithelial cells. Infect. Immun. 60(6), 2211-2217 (1992).
79. Vuopio-Varkila J, Schoolnik GK: Localized adherence by enteropathogenic Escherichia coli is an inducible phenotype associated with the expression of new outer membrane proteins. J. Exp. Med. 174(5), 1167-1177 (1991).
80. Saldana Z, Xicohtencatl-Cortes J, Avelino F et al.: Synergistic role of curli and cellulose in cell adherence and bioflm formation of attaching and effacing Escherichia coli and identifcation of Fis as a negative regulator of curli. Environ. Microbiol. 11(4), 992-1006 (2009).
81. Schriefer A, Maltez JR, Silva N, Stoeckle MY, Barral-Netto M, Riley LW: Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live Salmonella vaccine strain. Vaccine 17(7-8), 770-778 (1999).
82. Tobe T, Sasakawa C: Role of bundle-forming pilus of enteropathogenic Escherichia coli in host cell adherence and in microcolony development. Cell. Microbiol. 3(9), 579-585 (2001).
83. Cleary J, Lai LC, Shaw RK et al.: Enteropathogenic Escherichia coli (EPEC) adhesion to intestinal epithelial cells: role of bundle-forming pili (BFP), EspA flaments and intimin. Microbiology 150(Pt 3), 527-538 (2004).
84. Saldana Z, Erdem AL, Schuller S et al.: The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. coli. J. Bacteriol. 191(11), 3451-3461 (2009).
85. Hicks S, Frankel G, Kaper JB, Dougan G, Phillips AD: Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro. Infect. Immun. 66(4), 1570-1578 (1998).
86. Humphries RM, Waterhouse CC, Mulvey G, Beck P, Armstrong GD: Interactions of enteropathogenic Escherichia coli with pediatric and adult intestinal biopsy specimens during early adherence. Infect. Immun. 77(10), 4463-4468. (2009).
87. Knutton S, Rosenshine I, Pallen MJ et al.: A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 17(8), 2166-2176 (1998).
88. Hyland RM, Sun J, Griener TP et al.: The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin. Cell. Microbiol. 10(1), 177-187 (2008).
89. Humphries RM, Donnenberg MS, Strecker J et al.: From a to p: identifcation of amino acids required for the N-acetyllactosamine- specific lectin-like activity of bundlin. Mol. Microbiol. 72(4), 859-868 (2009).
90. Vanmaele RP, Finlayson MC, Armstrong GD: Effect of enteropathogenic Escherichia coli on adherent properties of Chinese hamster ovary cells. Infect. Immun. 63(1), 191-198 (1995).
91. Vanmaele RP, Heerze LD, Armstrong GD: Role of lactosyl glycan sequences in inhibiting enteropathogenic Escherichia coli attachment. Infect. Immun. 67(7), 3302-3307 (1999).
92. Hyland RM, Beck P, Mulvey GL, Kitov PI, Armstrong GD: N-acetyllactosamine conjugated to gold nanoparticles inhibits enteropathogenic Escherichia coli colonization of the epithelium in human intestinal biopsy specimens. Infect. Immun. 74(9), 5419-5421 (2006).
93. Cravioto A, Tello A, Villafan H, Ruiz J, del Vedovo S, Neeser JR: Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J. Infect. Dis. 163(6), 1247-1255 (1991).
94. Jagannatha HM, Sharma UK, Ramaseshan T, Surolia A, Balganesh TS: Identifcation of carbohydrate structures as receptors for localised adherent enteropathogenic Escherichia coli. Microb. Pathog. 11(4), 259-268 (1991).
95. Scaletsky IC, Milani SR, Trabulsi LR, Travassos LR: Isolation and characterization of the localized adherence factor of enteropathogenic Escherichia coli. Infect. Immun. 56(11), 2979-2983 (1988).
96. Bray J, Beavan TED: Slide agglutination of Bacterium coli var. neapolitanum in summer diarrhoea. J. Pathol. Bacteriol. 60(3), 395-401 (1948).
97. Bray J: Isolation of antigenically homogenous strains of Bact. coli neapolitanum from summer diarrhoea of infants. J. Pathol. Bacteriol. 57, 239-247 (1945).
98. Barnett Foster D, Philpott D, Abul-Milh M, Huesca M, Sherman PM, Lingwood CA: Phosphatidylethanolamine recognition promotes enteropathogenic E. coli and enterohemorrhagic E. coli host cell attachment. Microb. Pathog. 27(5), 289-301 (1999).
99. Khursigara C, Abul-Milh M, Lau B, Giron JA, Lingwood CA, Foster DE: Enteropathogenic Escherichia coli virulence factor bundle-forming pilus has a binding specificity for phosphatidylethanolamine. Infect. Immun. 69(11), 6573-6579 (2001).
100. Adu-Bobie J, Frankel G, Bain C et al.: Detection of intimins a, p, y, and d, four intimin derivatives expressed by attaching and effacing microbial pathogens. J. Clin. Microbiol. 36(3), 662-668 (1998).
101. Oswald E, Schmidt H, Morabito S, Karch H, Marches O, Caprioli A: Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect. Immun. 68(1), 64-71 (2000).
102. Zhang WL, Kohler B, Oswald E et al.: Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains. J. Clin. Microbiol. 40(12), 4486-4492 (2002).
103. Tarr CL, Whittam TS: Molecular evolution of the intimin gene in O111 clones of pathogenic Escherichia coli. J. Bacteriol. 184(2), 479-487 (2002).
104. Hernandes RT, Silva RM, Carneiro SM et al.: The localized adherence pattern of an atypical enteropathogenic Escherichia coli is mediated by intimin omicron and unexpectedly promotes HeLa cell invasion. Cell. Microbiol. 10(2), 415-425 (2008).
105. Jores J, Zehmke K, Eichberg J, Rumer L, Wieler LH: Description of a novel intimin variant (type Q in the bovine O84:NM verotoxin-producing Escherichia coli strain 537/89 and the diagnostic value of intimin typing. Exp. Biol. Med. (Maywood) 228(4), 370-376 (2003).
106. Sinclair JF, O'Brien AD: Intimin types a, p, and y bind to nucleolin with equivalent affnity but lower avidity than to the translocated intimin receptor. J. Biol. Chem. 279(32), 33751-33758 (2004).
107. Sinclair JF, O'Brien AD: Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-y of enterohemorrhagic Escherichia coli O157:H7. J. Biol. Chem. 277(4), 2876-2885 (2002).
108. Giron JA, Torres AG, Freer E, Kaper JB: The fagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol. Microbiol. 44(2), 361-379 (2002).
109. Rendon MA, Saldana Z, Erdem AL et al.: Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc. Natl Acad. Sci. USA 104(25), 10637-10642 (2007).
110. McDaniel TK, Kaper JB: A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol. Microbiol. 23(2), 399-407 (1997).
111. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB: A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl Acad. Sci. USA 92(5), 1664-1668 (1995).
112. Elliott SJ, Wainwright LA, McDaniel TK et al.: The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol. Microbiol. 28(1), 1-4 (1998).
113. Garmendia J, Frankel G, Crepin VF: Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect. Immun. 73(5), 2573-2585 (2005). (Pubitemid 40570322)
114. Gauthier A, Puente JL, Finlay BB: Secretin of the enteropathogenic Escherichia coli type III secretion system requires components of the type III apparatus for assembly and localization. Infect. Immun. 71(6), 3310-3319 (2003). (Pubitemid 36637557)
115. Crepin VF, Prasannan S, Shaw RK et al.: Structural and functional studies of the enteropathogenic Escherichia coli type III needle complex protein EscJ. Mol. Microbiol. 55(6), 1658-1670 (2005).
116. Ogino T, Ohno R, Sekiya K et al.: Assembly of the type III secretion apparatus of enteropathogenic Escherichia coli. J. Bacteriol. 188(8), 2801-2811 (2006).
117. Woestyn S, Allaoui A, Wattiau P, Cornelis GR: YscN, the putative energizer of the Yersinia Yop secretion machinery J. Bacteriol. 176(6), 1561-1569 (1994).
118. Akeda Y, Galan JE: Genetic analysis of the Salmonella enterica type III secretion-associated ATPase InvC defnes discrete functional domains. J. Bacteriol. 186(8), 2402-2412 (2004).
119. Crepin VF, Shaw R, Abe CM, Knutton S, Frankel G: Polarity of enteropathogenic Escherichia coli EspA flament assembly and protein secretion. J. Bacteriol. 187(8), 2881-2889 (2005).
120. Daniell SJ, Kocsis E, Morris E, Knutton S, Booy FP, Frankel G: 3D structure of EspA flaments from enteropathogenic Escherichia coli. Mol. Microbiol. 49(2), 301-308 (2003).
121. Daniell SJ, Delahay RM, Shaw RK et al.: Coiled-coil domain of enteropathogenic Escherichia coli type III secreted protein EspD is involved in EspA flament-mediated cell attachment and hemolysis. Infect. Immun. 69(6), 4055-4064 (2001).
122. Shaw RK, Daniell S, Ebel F, Frankel G, Knutton S: EspA flament-mediated protein translocation into red blood cells. Cell. Microbiol. 3(4), 213-222 (2001).
123. Hartland EL, Daniell SJ, Delahay RM et al.: The type III protein translocation system of enteropathogenic Escherichia coli involves EspA-EspB protein interactions. Mol. Microbiol. 35(6), 1483-1492 (2000).
124. Kenny B, Lai LC, Finlay BB, Donnenberg MS: EspA, a protein secreted by enteropathogenic Escherichia coli, is required to induce signals in epithelial cells. Mol. Microbiol. 20(2), 313-323 (1996).
125. Wilson RK, Shaw RK, Daniell S, Knutton S, Frankel G: Role of EscF, a putative needle complex protein, in the type III protein translocation system of enteropathogenic Escherichia coli. Cell. Microbiol. 3(11), 753-762 (2001).
126. Singh MP, Shaw RK, Knutton S, Pallen MJ, Crepin VF, Frankel G: Identifcation of amino acid residues within the N-terminal domain of EspA that play a role in EspA flament biogenesis and function. J. Bacteriol. 190(6), 2221-2226 (2008).
127. Kodama T, Akeda Y, Kono G et al.: The EspB protein of enterohaemorrhagic Escherichia coli interacts directly with a-catenin. Cell. Microbiol. 4(4), 213-222 (2002).
128. Ide T, Laarmann S, Greune L, Schillers H, Oberleithner H, Schmidt MA: Characterization of translocation pores inserted into plasma membranes by type III-secreted Esp proteins of enteropathogenic Escherichia coli. Cell. Microbiol. 3(10), 669-679 (2001).
129. Kresse AU, Rohde M, Guzman CA: The EspD protein of enterohemorrhagic Escherichia coli is required for the formation of bacterial surface appendages and is incorporated in the cytoplasmic membranes of target cells. Infect. Immun. 67(9), 4834-4842 (1999).
130. Creasey EA, Friedberg D, Shaw RK et al.: CesAB is an enteropathogenic Escherichia coli chaperone for the type-III translocator proteins EspA and EspB. Microbiology 149(Pt 12), 3639-3647 (2003).
131. Wainwright LA, Kaper JB: EspB and EspD require a specific chaperone for proper secretion from enteropathogenic Escherichia coli. Mol. Microbiol. 27(6), 1247-1260 (1998).
132. Neves BC, Mundy R, Petrovska L, Dougan G, Knutton S, Frankel G: CesD2 of enteropathogenic Escherichia coli is a second chaperone for the type III secretion translocator protein EspD. Infect. Immun. 71(4), 2130-2141 (2003).
133. Deng W, Li Y, Hardwidge PR et al.: Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens. Infect. Immun. 73(4), 2135-2146 (2005).
134. Allen-Vercoe E, Woodward MJ: The role of fagella, but not fmbriae, in the adherence of Salmonella enterica serotype Enteritidis to chick gut explant. J. Med. Microbiol. 48(8), 771-780 (1999).
135. Dean P, Maresca M, Schuller S, Phillips AD, Kenny B: Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc. Natl Acad. Sci. USA 103(6), 1876-1881 (2006).
136. Shaw RK, Cleary J, Murphy MS, Frankel G, Knutton S: Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions. Infect. Immun. 73 (2), 1243-1251 (2005).
137. Luo Y, Frey EA, Pfuetzner RA et al.: Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex. Nature 405 (6790), 1073-1077 (2000).
138. Ross NT, Mace CR, Miller BL: Biophysical analysis of the EPEC translocated intimin receptor-binding domain. Biochem. Biophys. Res. Commun. 362(4), 1073-1078 (2007).
139. Touze T, Hayward RD, Eswaran J, Leong JM, Koronakis V: Self-association of EPEC intimin mediated by the p-barrel-containing anchor domain: a role in clustering of the Tir receptor. Mol. Microbiol. 51(1), 73-87 (2004).
140. Frankel G, Candy DC, Everest P, Dougan G: Characterization of the C-terminal domains of intimin-like proteins of enteropathogenic and enterohemorrhagic Escherichia coli, Citrobacter freundii, and Hafnia alvei. Infect. Immun. 62(5), 1835-1842 (1994).
141. Bodelon G, Marin E, Angel Fernandez L: Role of periplasmic chaperones and BamA (YaeT/Omp85) in folding and secretion of intimin from enteropathogenic Escherichia coli strains. J. Bacteriol. 191, 5169-5179 (2009).
142. Dean P, Maresca M, Kenny B: EPEC's weapons of mass subversion. Curr. Opin. Microbiol. 8(1), 28-34 (2005).
143. Warawa J, Kenny B: Phosphoserine modifcation of the enteropathogenic Escherichia coli Tir molecule is required to trigger conformational changes in Tir and effcient pedestal elongation. Mol. Microbiol. 42(5), 1269-1280 (2001).
144. Campellone KG, Giese A, Tipper DJ, Leong JM: A tyrosine-phosphorylated 12-amino-acid sequence of enteropathogenic Escherichia coli Tir binds the host adaptor protein Nck and is required for Nck localization to actin pedestals. Mol. Microbiol. 43(5), 1227-1241 (2002).
145. Campellone KG, Rankin S, Pawson T, Kirschner MW, Tipper DJ, Leong JM: Clustering of Nck by a 12-residue Tir phosphopeptide is suffcient to trigger localized actin assembly. J. Cell. Biol. 164(3), 407-416 (2004).
146. DeVinney R, Puente JL, Gauthier A, Goosney D, Finlay BB: Enterohaemorrhagic and enteropathogenic Escherichia coli use a different Tir-based mechanism for pedestal formation. Mol. Microbiol. 41(6), 1445-1458 (2001).
147. Kalman D, Weiner OD, Goosney DL et al.: Enteropathogenic E. coli acts through WASP and Arp2/3 complex to form actin pedestals. Nat. Cell. Biol. 1(6), 389-391 (1999).
148. Lommel S, Benesch S, Rohde M, Wehland J, Rottner K: Enterohaemorrhagic and enteropathogenic Escherichia coli use different mechanisms for actin pedestal formation that converge on N-WASP. Cell. Microbiol. 6(3), 243-254 (2004).
149. Lommel S, Benesch S, Rottner K, Franz T, Wehland J, Kuhn R: Actin pedestal formation by enteropathogenic Escherichia coli and intracellular motility of Shigella fexneri are abolished in N-WASP-defective cells. EM BO Rep. 2(9), 850-857 (2001).
150. Whale AD, Hernandes RT, Ooka T et al.: TccP2-mediated subversion of actin dynamics by EPEC 2 - a distinct evolutionary lineage of enteropathogenic Escherichia coli. Microbiology 153 (Pt 6), 1743-1755 (2007).
151. Alto NM, Wefen AW, Rardin MJ et al.: The type III effector EspF coordinates membrane traffcking by the spatiotemporal activation of two eukaryotic signaling pathways. J. Cell. Biol. 178(7), 1265-1278 (2007).
152. Marches O, Batchelor M, Shaw RK et al.: EspF of enteropathogenic Escherichia coli binds sorting nexin 9. J. Bacteriol. 188(8), 3110-3115 (2006).
153. Bai L, Schuller S, Whale A et al.: Enteropathogenic Escherichia coli O125: H6 triggers attaching and effacing lesions on human intestinal biopsy specimens independently of Nck and TccP/TccP2. Infect. Immun. 76(1), 361-368 (2008).
154. Finlay BB, Rosenshine I, Donnenberg MS, Kaper JB: Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells. Infect. Immun. 60(6), 2541-2543 (1992).
155. Manjarrez-Hernandez HA, Amess B, Sellers L et al.: Purifcation of a 20 kDa phosphoprotein from epithelial cells and identifcation as a myosin light chain. Phosphorylation induced by enteropathogenic Escherichia coli and phorbol ester. FEBS Lett. 292(1-2), 121-127 (1991).
156. Kim M, Ogawa M, Fujita Y et al.: Bacterial hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. Nature 459, 578-582 (2009).
157. Knutton S, Shaw RK, Anantha RP, Donnenberg MS, Zorgani AA: The type IV bundle-forming pilus of enteropathogenic Escherichia coli undergoes dramatic alterations in structure associated with bacterial adherence, aggregation and dispersal. Mol. Microbiol. 33(3), 499-509 (1999).
158. Martinez-Laguna Y, Calva E, Puente JL: Autoactivation and environmental regulation of bfpT expression, the gene coding for the transcriptional activator of bfpA in enteropathogenic Escherichia coli. Mol. Microbiol. 33(1), 153-166 (1999).
159. Mellies JL, Elliott SJ, Sperandio V, Donnenberg MS, Kaper JB: The Per regulon of enteropathogenic Escherichia coli: identifcation of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol. Microbiol. 33(2), 296-306 (1999).
160. Porter ME, Mitchell P, Roe AJ, Free A, Smith DG, Gally DL: Direct and indirect transcriptional activation of virulence genes by an AraC-like protein, PerA from enteropathogenic Escherichia coli. Mol. Microbiol. 54(4), 1117-1133 (2004).
161. Bustamante VH, Santana FJ, Calva E, Puente JL: Transcriptional regulation of type III secretion genes in enteropathogenic Escherichia coli: Ler antagonizes H-NS-dependent repression. Mol. Microbiol. 39(3), 664-678 (2001).
162. Goldberg MD, Johnson M, Hinton JC, Williams PH: Role of the nucleoid-associated protein Fis in the regulation of virulence properties of enteropathogenic Escherichia coli. Mol. Microbiol. 41(3), 549-559 (2001).
163. Macritchie DM, Ward JD, Nevesinjac AZ, Raivio TL: Activation of the Cpx envelope stress response down-regulates expression of several locus of enterocyte effacement-encoded genes in enteropathogenic Escherichia coli. Infect. Immun. 76(4), 1465-1475 (2008).
164. Nevesinjac AZ, Raivio TL: The Cpx envelope stress response affects expression of the type IV bundle-forming pili of enteropathogenic Escherichia coli. J. Bacteriol. 187(2), 672-686 (2005).
165. Vogt SL, Nevesinjac AZ, Donnenberg M, Armstrong GD, Raivio TL: The Cpx envelope stress response both facilitates and inhibits elaboration of the enteropathogenic Escherichia coli bundle forming pilus. Mol. Microbiol. 76(5), 1095-1110 (2010).
166. Sircili MP, Walters M, Trabulsi LR, Sperandio V: Modulation of enteropathogenic Escherichia coli virulence by quorum sensing. Infect. Immun. 72(4), 2329-2337 (2004).
167. Hyland RM, Griener TP, Mulvey GL et al.: Basis for N-acetyllactosamine- mediated inhibition of enteropathogenic Escherichia coli localized adherence. J. Med. Microbiol. 55(Pt 6), 669-675 (2006).
168. Donnenberg MS: Interactions between enteropathogenic Escherichia coli and
169. Stone KD, Zhang HZ, Carlson LK, Donnenberg MS: A cluster of fourteen genes from enteropathogenic Escherichia coli is suffcient for the biogenesis of a type IV pilus. Mol. Microbiol. 20(2), 325-337 (1996).